Clinical development of nintedanib for advanced non-small-cell lung cancer

Angiogenesis is an essential process in the development, growth, and metastasis of malignant tumors including lung cancer. Several angiogenesis inhibitors have been developed as potential therapies for non-small-cell lung cancer (NSCLC). Nintedanib is a small-molecule tyrosine kinase inhibitor that...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeda, Masayuki, Okamoto, Isamu, Nakagawa, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654540/
https://www.ncbi.nlm.nih.gov/pubmed/26622180
http://dx.doi.org/10.2147/TCRM.S76646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654540/
https://www.ncbi.nlm.nih.gov/pubmed/26622180
http://dx.doi.org/10.2147/TCRM.S76646

Ejemplares similares